These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 36454256)
1. Nobiletin is capable of regulating certain anti-cancer pathways in a colon cancer cell line. Kisacam MA Naunyn Schmiedebergs Arch Pharmacol; 2023 Mar; 396(3):547-555. PubMed ID: 36454256 [TBL] [Abstract][Full Text] [Related]
2. Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells. Lee YC; Cheng TH; Lee JS; Chen JH; Liao YC; Fong Y; Wu CH; Shih YW Mol Cell Biochem; 2011 Jan; 347(1-2):103-15. PubMed ID: 20963626 [TBL] [Abstract][Full Text] [Related]
3. The flavonoid nobiletin inhibits tumor growth and angiogenesis of ovarian cancers via the Akt pathway. Chen J; Chen AY; Huang H; Ye X; Rollyson WD; Perry HE; Brown KC; Rojanasakul Y; Rankin GO; Dasgupta P; Chen YC Int J Oncol; 2015; 46(6):2629-38. PubMed ID: 25845666 [TBL] [Abstract][Full Text] [Related]
4. Nobiletin suppresses cell viability through AKT pathways in PC-3 and DU-145 prostate cancer cells. Chen J; Creed A; Chen AY; Huang H; Li Z; Rankin GO; Ye X; Xu G; Chen YC BMC Pharmacol Toxicol; 2014 Oct; 15():59. PubMed ID: 25342300 [TBL] [Abstract][Full Text] [Related]
5. Nobiletin, a Polymethoxylated Flavone, Inhibits Glioma Cell Growth and Migration via Arresting Cell Cycle and Suppressing MAPK and Akt Pathways. Lien LM; Wang MJ; Chen RJ; Chiu HC; Wu JL; Shen MY; Chou DS; Sheu JR; Lin KH; Lu WJ Phytother Res; 2016 Feb; 30(2):214-21. PubMed ID: 26560814 [TBL] [Abstract][Full Text] [Related]
6. In vitro studies on nobiletin isolated from citrus plants and the bioactive metabolites, inhibitory action against gelatinase enzymatic activity and the molecular mechanisms in human retinal Müller cell line. Miyata Y; Nagase T; Katsura Y; Takahashi H; Natsugari H; Oshitari T; Kosano H Biomed Pharmacother; 2017 Sep; 93():70-80. PubMed ID: 28623785 [TBL] [Abstract][Full Text] [Related]
7. Nobiletin sensitizes colorectal cancer cells to oxaliplatin by PI3K/Akt/MTOR pathway. Li N; Zhang Z; Jiang G; Sun H; Yu D Front Biosci (Landmark Ed); 2019 Jan; 24(2):303-312. PubMed ID: 30468657 [TBL] [Abstract][Full Text] [Related]
8. Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9. Baek SH; Kim SM; Nam D; Lee JH; Ahn KS; Choi SH; Kim SH; Shim BS; Chang IM; Ahn KS Pharm Biol; 2012 Oct; 50(10):1210-8. PubMed ID: 22853317 [TBL] [Abstract][Full Text] [Related]
9. Activation of protein kinase C betaII/epsilon-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin. Miyata Y; Sato T; Yano M; Ito A Mol Cancer Ther; 2004 Jul; 3(7):839-47. PubMed ID: 15252145 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of 4EBP1, p70S6K, Akt1 or Akt2 differentially promotes Coxsackievirus B3-induced apoptosis in HeLa cells. Li X; Li Z; Zhou W; Xing X; Huang L; Tian L; Chen J; Chen C; Ma X; Yang Z Cell Death Dis; 2013 Sep; 4(9):e803-9. PubMed ID: 24030155 [TBL] [Abstract][Full Text] [Related]
11. 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice. Wang C; Cigliano A; Jiang L; Li X; Fan B; Pilo MG; Liu Y; Gui B; Sini M; Smith JW; Dombrowski F; Calvisi DF; Evert M; Chen X Hepatology; 2015 Jan; 61(1):200-13. PubMed ID: 25145583 [TBL] [Abstract][Full Text] [Related]
12. Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells. Shi MD; Liao YC; Shih YW; Tsai LY Phytomedicine; 2013 Jun; 20(8-9):743-52. PubMed ID: 23537747 [TBL] [Abstract][Full Text] [Related]
13. Nobiletin ameliorates isoflurane-induced cognitive impairment via antioxidant, anti-inflammatory and anti-apoptotic effects in aging rats. Bi J; Zhang H; Lu J; Lei W Mol Med Rep; 2016 Dec; 14(6):5408-5414. PubMed ID: 27840933 [TBL] [Abstract][Full Text] [Related]
14. 5,3'-Dihydroxy-6,7,4'-trimethoxyflavanone exerts its anticancer and antiangiogenesis effects through regulation of the Akt/mTOR signaling pathway in human lung cancer cells. Kim KM; Heo DR; Lee J; Park JS; Baek MG; Yi JM; Kim H; Bang OS Chem Biol Interact; 2015 Jan; 225():32-9. PubMed ID: 25446852 [TBL] [Abstract][Full Text] [Related]
15. [Inhibition effect and its mechanism of nobiletin on proliferation of lung cancer cells]. Luo G; Zeng Y; Zhu L; Zhang YX; Zhou LM Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):449-53. PubMed ID: 19627003 [TBL] [Abstract][Full Text] [Related]
16. Nobiletin induces apoptosis and potentiates the effects of the anticancer drug 5-fluorouracil in p53-mutated SNU-16 human gastric cancer cells. Moon JY; Cho M; Ahn KS; Cho SK Nutr Cancer; 2013; 65(2):286-95. PubMed ID: 23441616 [TBL] [Abstract][Full Text] [Related]
17. Nobiletin protects against myocardial injury and myocardial apoptosis following coronary microembolization via activating PI3K/Akt pathway in rats. Mao Q; Liang X; Wu Y; Lu Y Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1121-1130. PubMed ID: 31073648 [TBL] [Abstract][Full Text] [Related]
18. Nobiletin inhibits viability of human renal carcinoma cells via the JAK2/STAT3 and PI3K/Akt pathway. Xu Z; Wu D; Fu D; Tang C; Ge J; Zhang Z; Zhou W Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):199-203. PubMed ID: 33040836 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy. Valianou M; Cox AM; Pichette B; Hartley S; Paladhi UR; Astrinidis A Cell Cycle; 2015; 14(3):399-407. PubMed ID: 25565629 [TBL] [Abstract][Full Text] [Related]
20. Nobiletin induces inhibitions of Ras activity and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling to suppress cell proliferation in C6 rat glioma cells. Aoki K; Yokosuka A; Mimaki Y; Fukunaga K; Yamakuni T Biol Pharm Bull; 2013; 36(4):540-7. PubMed ID: 23546290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]